Clinical Trial Update: Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing the safety and potential efficacy of human umbilical cord-derived mesenchymal stem cells for HBV-related liver cirrhosis; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Liver Cirrhosis

Drugs mentioned

• Human Umbilical Cord-derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Liver Cirrhosis, End Stage Liver Disease | Phase 1, Phase 2 | Status: UNKNOWN